Cargando…

SG-APSIC1199: Evaluation of a pooling strategy using Xpert Carba-R assay for screening for carbapenemase-producing organisms in rectal swabs

Objectives: Rapid and accurate screening for carbapenemase-producing organism (CPOs) in hospitalized patients is critical for infection control and prevention. The Xpert Carba-R assay is designed for rapid detection of CPOs, but 1 assay is usually conducted for only 1 sample. We evaluated a pooling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peng, Wang, Qi, Zhou, Chaoe, Gao, Xinghui, Tang, Yi-wei, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Multidrug-Resistant (MDR) Organisms
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571200/ http://dx.doi.org/10.1017/ash.2023.79

Ejemplares similares

SG-APSIC1159: Control of hospital-acquired carbapenemase-producing carbapenem-resistant Enterobacteriaceae colonization: A descriptive study
por: Wu, Tuodi, et al.
Publicado: (2023)

SG-APSIC1083: Prevalence and classification of carbapenemase-producing gram-negative bacilli at a medical center in Ho Chi Minh City, Vietnam
por: Huynh, Tuan, et al.
Publicado: (2023)

SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
por: Husen, Sharifah Farhanah Syed, et al.
Publicado: (2023)

SG-APSIC1096: Changes in resistance patterns of “ESKAPE” pathogens to azithromincin and levofloxacin in Yogyakarta
por: Asdie, Rizka, et al.
Publicado: (2023)

SG-APSIC1164: Cost-effectiveness of temporary isolation rooms in acute-care settings in Asia
por: Graves, Nicholas, et al.
Publicado: (2023)

SG-APSIC1080: Surveillance and control efforts for carbapenemase-producing gram-negative bacteria at a high-burden tertiary-care healthcare facility in Ho Chi Minh City, Vietnam
por: Huynh, Tuan, et al.
Publicado: (2023)

SG-APSIC1081: Healthcare cost of antibiotic resistant infections: A hospital-based study in Vietnam
por: LanPham, Thi, et al.
Publicado: (2023)

SG-APSIC1123: Diagnostic and infection prevention and control (IPC) performance of rapid polymerase chain reaction (PCR) compared to conventional culture PCR methods for detecting carbapenemase-producing organisms (CPOs)
por: Huan, Xiaowei, et al.
Publicado: (2023)

SG-APSIC1203: Detection of carbapenemase genes in donor lungs at the point of care before transplantation reduces the risk of carbapenem-resistant Enterobacteriaceae–associated donor-derived infection in lung-transplant recipients
por: Zhou, Wenyong, et al.
Publicado: (2023)

SG-APSIC1136: Multidrug-resistant organisms: Elevating issues identified by antimicrobial stewardship to improve infection control responses
por: Sheehan, Frances, et al.
Publicado: (2023)

SG-APSIC1102: Antimicrobial resistance and related factors in an intensive care unit—A study at Hue Central Hospital
por: Dang, Tan, et al.
Publicado: (2023)

SG-APSIC1097: The impact of COVID-19 on the incidence of carbapenem-resistant Enterobacterales (CRE) in Singapore: An interrupted time-series analysis
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

SG-APSIC1209: Risk factors associated with mortality among carbapenem-resistant Enterobacteriaceae inpatient in a tertiary-care teaching hospital in Malaysia
por: Sri Ponnampalavanar, Sasheela Sri La, et al.
Publicado: (2023)

SG-APSIC1157: The attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections—A prospective cohort study in Suva, Fiji
por: Loftus, Michael, et al.
Publicado: (2023)

SG-APSIC1069: Implementing infection prevention bundle significantly reduced multidrug-resistant organisms infection and healthcare-associated infections in intensive care unit at a national hospital in Vietnam
por: Phung, Thang, et al.
Publicado: (2023)

SG-APSIC1073: Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis
por: Ling, Weiping, et al.
Publicado: (2023)

Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs
por: Tato, M., et al.
Publicado: (2016)

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

Evaluation of Xpert Carba-R Assay for the Detection of Carbapenemase Genes in Gram-Negative Bacteria
por: Li, Hou-He, et al.
Publicado: (2021)

Diagnostic performance of the Xpert Carba-R assay for active surveillance of rectal carbapenemase-producing organisms in intensive care unit patients
por: Ko, Young Jin, et al.
Publicado: (2019)

Evaluation of Xpert Carba-R for detecting carbapenemase-producing organisms in South Africa
por: Duze, Sanelisiwe T., et al.
Publicado: (2023)

Xpert Carba-R assay for detection of carbapenemase-producing organisms in patients admitted to emergency rooms
por: Jin, Sol, et al.
Publicado: (2020)

Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
por: Gu, Danxia, et al.
Publicado: (2023)

Evaluation of Xpert Carba-R Assay v.2 to Detect Carbapenemase Genes in Two Hospitals in Korea
por: Byun, Jung-Hyun, et al.
Publicado: (2020)

Rapid Carbapenemase Detection With Xpert Carba-R V2 Directly On Positive Blood Vials
por: Cointe, Aurélie, et al.
Publicado: (2019)

A Rapid Carbapenemase Genes Detection Method with Xpert Carba-R from Positive Blood Cultures Compared with NG-Test Carba 5 and Sequencing
por: Xu, Yuqiao, et al.
Publicado: (2022)

Molecular Detection of Carbapenemase Enzymes Directly from Positive Blood Cultures Using Xpert Carba-R
por: Nayak, Gayatree, et al.
Publicado: (2022)

Detection of Carbapenem-resistance in CRE by Comparative Assessment of RAPIDEC(®) CARBA NP and Xpert™Carba-R Assay
por: Eltahlawi, Rehab A, et al.
Publicado: (2023)

Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022)

Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital
por: Kim, Do-Kyun, et al.
Publicado: (2016)

Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture Positivity
por: Seo, Hyeonji, et al.
Publicado: (2022)

SG-APSIC1182: Sequential time workforce management
por: Sirijindadirat, Nanthipha
Publicado: (2023)

SG-APSIC1047: Patient instrument tracking system
por: Sirijindadirat, Nanthipha, et al.
Publicado: (2023)

AI-Blue-Carba: A Rapid and Improved Carbapenemase Producer Detection Assay Using Blue-Carba With Deep Learning
por: Jia, Ling, et al.
Publicado: (2020)

Time Above All Else: Pharmacodynamic Analysis of Β-Lactams in Critically Ill Patients
por: Landmesser, Katherine, et al.
Publicado: (2021)

Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021)

Treatment of Extensively Drug-Resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) Medical Centers
por: Fitzpatrick, Margaret, et al.
Publicado: (2021)

How Does Antimicrobial Resistance Increase Medical Costs in Community-Acquired Acute Pyelonephritis?
por: Kim, Bongyoung, et al.
Publicado: (2021)

Stewardship Nightmare: Ceftolozane/Tazobactam–Resistant Pseudomonas aeruginosa Infections Accelerated by the COVID-19 Pandemic
por: Haviland, Adam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ir5shk8do40hvcfdk9brp6mgb3